News & Events
ChemGenex, Hospira, Announce Agreement to License, Develop and Commercialize Leukemia Drug in Europe
18 / 12 / 2009
ChemGenex to Present Positive Data for Omaproâ?¢ from Multiple Clinical Trials at ASH
01 / 12 / 2009
ChemGenexâ??s Marketing Authorization Application for Omacetaxine Mepesuccinate Validated by the European Medicines Agency
27 / 11 / 2009
LEO Pharma Completes Peplin Acquisition; Peplin to Continue as an Independent Subsidiary
12 / 11 / 2009
ChemGenex Announces FDA Accepts NDA for Omaproâ?¢ (Omacetaxine Mepesuccinate) and Grants the Filing Priority Review Status
10 / 11 / 2009
WOMENâ??S SEXUAL HEALTH COMPANY CHANGES NAME IN PREPARATION FOR MARKET ENTRY TivaMed Becomes Viveve
09 / 11 / 2009
Sunshine Heart - C-Pulse US Clinical Update Highlights Well Being of Four Initial Clinical Trial Patients
21 / 09 / 2009
ChemGenex Submits New Drug Application for OMAPROâ?¢ (Omacetaxine Mepesuccinate) to U.S. FDA
09 / 09 / 2009
Novasys - Renessa® Treatment for Female Incontinence Gets Expanded Medicare Coverage
01 / 09 / 2009
Verva Announces License of Key FGFR Intellectual Property to Isis Pharmaceuticals, Inc. for the Treatment of Obesity and Other Diseases
20 / 08 / 2009
Displaying records 1-25 of 59